Im glad I ordered it because Im finally loosing weight I cant believe how quickly i received it
If and when retatrutide does get FDA approval, itll be especially important to monitor the drug while long-term safety and real patient side effects are still being established
On the scale, top doses run about 20.9 percent for tirzepatide versus 24.2 percent for retatrutide, and retatrutide hit its number in a shorter window at that
Women and reproductive considerations Women make up the majority of GLP-1 medication users, and a few considerations are unique to this population
New research presented at the Endocrine Societys 2025 Annual Meeting (ENDO 2025) has revealed that tirzepatidea medication originally developed for weight loss and type 2 diabetesmay offer surprising benefits for men suffering from both obesity and functional hypogonadism (low testosterone due to metabolic causes)
We now review the potential kidney health implications of tirzepatide, addressing its structure and function, relationship to current GLP1 receptor agonists, impact of recent results for the treatment and prevention of kidney disease, and expectations for the future